Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of updated shots also came several weeks later than usual, an
(Financial Post, 2025-11-04T14:49:02Z)